BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2018 3:36:55 AM | Browse: 650 | Download: 912
 |
Received |
|
2018-05-23 00:58 |
|
Peer-Review Started |
|
2018-05-25 00:11 |
|
To Make the First Decision |
|
2018-07-09 07:52 |
|
Return for Revision |
|
2018-07-10 08:21 |
|
Revised |
|
2018-09-07 07:34 |
|
Second Decision |
|
2018-11-01 02:24 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-11-03 04:50 |
|
Articles in Press |
|
2018-11-03 04:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-11-26 06:20 |
|
Publish the Manuscript Online |
|
2018-12-14 03:36 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Moussab Damlaj, Mohammad Snnallah, Ayman Alhejazi, Samer Ghazi, Bader Alahmari, Ahmed Alaskar and Mohsen Alzahrani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Moussab Damlaj, FACP, FRCP (C), MD, Assistant Professor, Doctor, Division of Hematology and HCT, Department of Oncology, King Abdulaziz Medical City, P.O. Box 22490, Riyadh 11426, Saudi Arabia. damlajmo@ngha.med.sa |
| Key Words |
Acute lymphoblastic leukemia; Allogeneic hematopoietic stem cell transplant; Lymphoblastic lymphoma; Complete remission |
| Core Tip |
Allogeneic hematopoietic stem cell transplantation (HCT) is a potentially curative therapy for acute lymphoblastic leukemia/lymphoma (ALL/LBL) patients. We examined the outcome and prognostic factors of HCT for high risk ALL/LBL at our center. After due institutional review board approval, 69 patients were enrolled. After a median follow up of 15 mo (2-87.3), the 2-year overall survival (OS) was 62.8%. In a multivariable analysis; B-cell subtype, first complete remission status, acute graft vs host disease (GVHD) and chronic GVHD predicted OS. In conclusion, allogeneic-HCT for ALL/LBL results in promising remissions in high risk disease and early referral for HCT to be considered for young and fit patients. |
| Publish Date |
2018-12-14 03:36 |
| Citation |
Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-Zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World J Transplant 2018; 8(7): 252-258 |
| URL |
http://www.wjgnet.com/2220-3230/full/v8/i7/252.htm |
| DOI |
http://dx.doi.org/10.5500/wjt.v8.i7.252 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
